Mineralys Therapeutics Net Tangible Assets

Mineralys Therapeutics (MLYS) currently reports a net tangible assets of $550M as of June 2026. That compares with $310M in the prior-year period — up 75.7% year over year. Use the charts on this page to explore Mineralys Therapeutics's net tangible assets history and peer comparisons.

Mineralys Therapeutics's net tangible assets increased from $310M to $550M — a 75.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mineralys Therapeutics reported $550M in net tangible assets as of June 2026. That compares with $310M in the prior-year period — up 75.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $550M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mineralys Therapeutics, and consider following MLYS for alerts when major investors trade the stock.